Earlier this year Professor Tasuku Honjo, Nobel Laureate, publicly criticized his development partner Ono Pharmaceuticals, claiming their renumeration (2.6 billion yen, about US$24 million) was far below what he and other researchers should receive, considering the value of the programmed…
Read more
The Japanese government’s Subcommittee on the Patent Act System has been working on revisions to the patent litigation system in Japan since October last year. The Japanese patent system does not have a requirement like the United States power of…
Read more
In a possibly consequential decision, the IP High Court overturned the Tokyo District Court’s infringement case decision against Debiopharm International S.A., judging that plaintiff Nichi-Iko’s patent No. 4430229 was not infringed. What was important about the decision was that the…
Read more